INKT ▲ +5.6% - MiNK Therapeutics, Inc. $INKT - MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy 02-NOV-2026 04:35 PM ET